Listen: Is 23andMe Trading Your DNA? With Maria Liu from First Health Advisory Solutions

Name: Listen: Is 23andMe Trading Your DNA? With Maria Liu from First Health Advisory Solutions
Uploaded: 2018-08-10T15:11:43.000Z
Description: 23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies. As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about…

23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies. As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from First Health Advisory on MarketScale.

August 10, 2018, 3:11 PM UTC

23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies.

As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about the security concerns and potential worries that come with companies sharing medical data.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Part of this channel

First Health Advisory

News, updates, and expert insights from First Health Advisory.

Visit the channel →

Turn this into your own content

Create a free MarketScale workspace and publish your own experts. No credit card, no demo required.

Book a demo Start free

MarketScale platform

Want to launch your own podcast or show?

MarketScale gives B2B companies a full content studio: record, produce, and distribute your own channel. No agency, no crew, no guessing.

See how it works →

Keep exploring

Executive Thought Leadership
Put clinical leaders on the record.
State of GEO & AI Visibility
How B2B brands get cited by AI search.

healthcare Events

Future of Health Summit 2026

Jul 12, 2026 · Virtual

2026 HIMSS Global Health Conference & Exhibition

Aug 11, 2026 · Virtual

World Healthcare Congress 2026

Sep 14, 2026 · Virtual

See all healthcare events ›

Follow Healthcare Insights

Get new expert content in your inbox.

Become an Industry Voice

Share your expertise with 1,250+ B2B brands on MarketScale.

Apply to participate

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Run a free AI visibility check →Book a demo

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

Start free Book a demo

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace

One video edit a month, on us

AI writing, editing, and publishing tools

In-platform coaching to learn the system

More Healthcare Insights

Healthcare AI governance, data quality, and interoperability top industry agenda in mid-2026

The article discusses the challenges faced by healthcare IT leaders in terms of AI governance, data quality, and interoperability by mid-2026. A significant effort is being made to address data readiness challenges and to enhance health data exchange through a $1.3 million federal initiative. These topics are at the forefront of the industry's agenda to improve healthcare infrastructure and outcomes.

01AI governance gaps are challenging healthcare IT leaders.
02Data readiness is a critical concern in healthcare.
03Federal funding is supporting health data exchange initiatives.

Jul 2, 2026

Healthcare Supply Chain Has a Board-Level Governance Problem.

Healthcare providers recognize supply chain as a top financial lever, yet boards review it less than quarterly, creating a structural governance gap. This misalignment is driving 71% of organizations to replace or upgrade major supply chain applications within 24 months, with demand shifting toward integrated platforms that deliver board-level reporting and measurable ROI.

0183% of healthcare supply chain professionals report board-level review occurs less than quarterly despite 90% ranking supply chain as a top-three financial lever
0271% of health systems plan to replace or upgrade major supply chain applications in the next 24 months, driven by fragmented architectures and weak integration rather than platform failure
03Healthcare supply chain management market projected to grow from $3.94 billion in 2026 to $6.52 billion by 2031, driven by modernization replacing legacy systems under margin pressure

Jun 29, 2026

How Do You Work Around Hospital Operations?

The article discusses the unique challenges of conducting restoration or renovation work in hospitals without disrupting their essential operations. This requires meticulous planning and execution to ensure that patient care and facility access remain uninterrupted. The primary goal of such projects is to maintain hospital functionality while completing the necessary work.